Many of the world’s poorest communities are still threatened by deadly infectious diseases that have become rare in wealthier nations. That’s why the foundation has committed more than $27 billion to ...

to improve livelihoods for youth, women, and persons with disabilities aged 18–50 in Kaduna State through a graduation program focused on economic empowerment ...

to support coaching support for K-12 teachers.

Carmen Carpio leads the foundation’s engagement with multilateral development banks—including the World Bank, the Global Financing Facility, and the Lives and Livelihoods Fund—on shared global health ...

Last year, a man named Chuck Feeney died, at the age of 92. Feeney was a billionaire, but you might not have heard of him. He purposely led a low-profile life—he wore a ten-dollar watch and, in his ...

On foundation’s 25th anniversary, Bill Gates outlines ambitious goals, inspiration for donating most of his resources and new timeline to spend-down by 2045 “There are too many urgent problems to ...

I remember the day I first experienced artificial intelligence (AI) in education. It was the late ’90s, and I was a maths teacher at a school in London described as having “challenging circumstances.” ...

Whether we’re paying the rent, receiving a paycheck, splitting the cost of a meal, or simply buying a coffee, people in much of the world take digital banking for granted. Everything is handled with a ...

SEATTLE (July 13, 2022) - Today, the Bill & Melinda Gates Foundation announced its intent to increase its annual payout by 50% over pre-pandemic levels, to $9 billion annually by 2026—the result of ...

SEATTLE, November 2, 2021 – Today at the United Nations Climate Change Conference (COP26), the Bill & Melinda Gates Foundation pledged US $315 million to the CGIAR global agriculture research ...

This article was originally published on Gates Notes. When I first began thinking about how to give away my wealth, I did what I always do when I start a new project: I read a lot of books. I read ...

Many people first heard of monoclonal antibody drugs as a treatment early in the COVID-19 pandemic. At the time, these proteins, which are made in a lab and can provide passive immunity, were the best ...